A Biomarker could predict response of intravitreal injections in Diabetic Macular Edema

(c) OMICS

Researchers at St. Michael’s Hospital have found an association with a biomarker from aqueous fluid in the eye that predicts which patients will respond best to current treatments for diabetic macular edema. Their findings suggest this biomarker may be not only a marker of disease severity and anatomic response but also a potential therapeutic target in DME, recognizing that in patients with DME, there is not always a direct correlation between anatomic and visual acuity response.